2m 2m 2m 2m 2m 2m 2m
DaVita (DVA)
NYSE
$235.39-$0.19 (-0.08%)
Price as of Jul 13, 2026 7:49 PM EDT- $14.9BMarket Cap
- 64.27%1-Year Change
- Medical Care FacilitiesIndustry
DaVita (DVA)
$235.39-$0.19 (-0.08%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 13.6B +6.46% | 12.8B +5.56% | 12.1B +4.57% | 11.6B -0.08% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 13.6B +6.46% | 12.8B +5.56% | 12.1B +4.57% | 11.6B -0.08% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 715.3M -1.18% | 723.9M -2.90% | 745.4M +1.75% | 732.6M +7.64% | |
Total Operating Expenses | 11.6B +8.15% | 10.7B +1.78% | 10.5B +2.60% | 10.3B +4.58% | |
Operating Profit | 2.0B -2.24% | 2.1B +30.43% | 1.6B +19.69% | 1.3B -25.50% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -539.9M +24.06% | -435.2M +16.38% | -374.0M +10.23% | -339.2M +27.04% | |
Interest Income and Expense and Net | -539.9M +24.06% | -435.2M +16.38% | -374.0M +10.23% | -339.2M +27.04% | |
Total Nonoperating Income and Expense | -102.7M +47.10% | -69.8M +264.02% | -19.2M +21.64% | -15.8M -347.18% | |
Income before Taxes | 1.3B -11.99% | 1.5B +30.01% | 1.2B +21.82% | 966.3M -36.37% | |
Income Taxes | 293.1M +4.81% | 279.7M +27.05% | 220.1M +11.12% | 198.1M -35.42% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 746.8M -20.24% | 936.3M +35.40% | 691.5M +23.40% | 560.4M -42.73% | |
Net Income from Continuing Operations Applicable to Common | 721.8M -22.91% | 936.3M +35.40% | 691.5M +26.44% | 546.9M -44.10% | |
Basic EPS and Net Income | 10.06 -8.71% | 11.02 +44.62% | 7.62 +26.37% | 6.03 -35.16% | |
Diluted EPS and Net Income | 9.84 -8.29% | 10.73 +44.61% | 7.42 +26.84% | 5.85 -34.27% | |
Basic Weighted Average Shares | 74.2M -12.66% | 85.0M -6.39% | 90.8M -2.37% | 93.0M -11.63% | |
Diluted Weighted Average Shares | 75.9M -13.05% | 87.3M -6.34% | 93.2M -2.77% | 95.8M -12.84% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 676.4M -14.91% | 794.9M +109.16% | 380.1M +55.71% | 244.1M -47.16% | |
Short-Term Investments | 24.3M -52.41% | 51.1M +339.83% | 11.6M -85.06% | 77.7M +248.24% | |
Cash and Cash Equivalents and Short-Term Investments | 700.7M -17.17% | 846.0M +116.00% | 391.7M +21.72% | 321.8M -33.55% | |
Total Current Assets | 4.1B +8.33% | 3.7B +19.38% | 3.1B -0.55% | 3.2B -0.39% | |
Accumulated Depreciation | 6.6B +5.42% | 6.3B +8.74% | 5.8B +9.38% | 5.3B +10.54% | |
Property and Plant and Equipment and Net | 2.8B -4.35% | 2.9B -4.31% | 3.1B -5.62% | 3.3B -6.42% | |
Total Long-Term Assets | 246.5M -5.81% | 261.7M -3.51% | 271.3M -14.05% | 315.6M +130.90% | |
Total Assets | 17.5B +1.13% | 17.3B +2.32% | 16.9B -0.20% | 16.9B -1.13% | |
Income Taxes Payable | 781.2M +15.62% | 675.7M -10.48% | 754.7M -5.76% | 800.8M -9.49% | |
Total Short-Term Debt | 109.2M -59.68% | 270.9M +119.68% | 123.3M -46.72% | 231.4M +29.25% | |
Total Current Liabilities | 3.1B +5.66% | 3.0B +12.53% | 2.6B +0.86% | 2.6B +9.22% | |
Total Long-Term Debt | 10.2B +10.77% | 9.2B +10.98% | 8.3B -4.88% | 8.7B -0.42% | |
Total Long-Term Liabilities | 83.5M -50.75% | 169.6M -7.37% | 183.1M +73.97% | 105.2M -11.69% | |
Total Liabilities | 16.3B +7.42% | 15.2B +7.38% | 14.2B -3.76% | 14.7B -0.32% | |
Retained Earnings | -328.4M -121.40% | 1.5B +156.50% | 598.3M +242.88% | 174.5M -50.76% | |
Total Stockholders Equity | -651.1M -637.54% | 121.1M -88.53% | 1.1B +48.26% | 712.3M -5.72% | |
Total Shares Outstanding | 68.5M -24.15% | 90.4M +1.74% | 88.8M -1.76% | 90.4M -7.07% | |
Cash Flow | |||||
Cash from Operating Activities | 1.9B -6.70% | 2.0B -1.80% | 2.1B +31.60% | 1.6B -18.97% | |
Capital Expenditures | 575.9M +3.68% | 555.4M -2.21% | 568.0M -5.87% | 603.4M -5.93% | |
Cash from Investing Activities | -654.9M -15.10% | -771.4M -0.05% | -771.8M +22.44% | -630.3M -19.67% | |
Dividends Paid | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Cash from Financing Activities | -1.4B +68.28% | -816.9M -30.21% | -1.2B +4.40% | -1.1B +3.52% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 14.98% -8.17% | 16.31% +23.55% | 13.20% +14.47% | 11.53% -25.44% | |
Return on Assets | 4.30% -21.59% | 5.48% +33.99% | 4.09% +24.23% | 3.29% -42.62% | |
Return on Equity | -281.83% -277.17% | 159.08% +103.40% | 78.21% +2.43% | 76.36% -16.53% | |
Revenue Growth | 6.46% +16.06% | 5.56% +21.81% | 4.57% +6,062.53% | -0.08% -112.97% | |
Current Ratio | 1.29 +2.52% | 1.26 +6.09% | 1.19 -1.39% | 1.20 -8.81% | |
Cash Ratio | 0.22 -19.45% | 0.27 +85.88% | 0.14 +54.29% | 0.09 -51.61% | |
Debt-to-Equity Ratio | -15.78 -120.23% | 77.99 +881.56% | 7.95 -36.57% | 12.53 +6.25% | |
Debt-to-Assets Ratio | 0.59 +7.54% | 0.55 +10.03% | 0.50 -5.79% | 0.53 +1.33% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow